z-logo
open-access-imgOpen Access
Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency
Author(s) -
Pavlína Králíčková,
Karolína Jankovičová,
Ilona Sejkorova,
Ondřej Souček,
Katerina Koprivova,
Marcela Drahošová,
Ctirad Andrýs,
Jan Krejsek
Publication year - 2022
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000526375
Subject(s) - common variable immunodeficiency , immunogenicity , immunology , medicine , vaccination , hypogammaglobulinemia , antibody , immunodeficiency , seroconversion , population , immune system , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom